Stay updated on GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.5.0 applied (updating from v3.4.3).SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No other content changes are visible on the page.SummaryDifference0.0%

- Check52 days agoChange Detected- The page footer now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1 as a minor update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, with no changes to study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedThe Study Record Dates section now displays Last Update Posted as the actual posting date and removes the Last Update Posted (Estimated) label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision update from v3.3.3 to v3.3.4 with no visible changes to the study content.SummaryDifference0.0%

Stay in the know with updates to GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.